ctrl K

Watchlist Price Alert

CinCor Pharma Inc. (CINC)

NASDAQ: CINC · Real-Time Price · USD

29.06

0.00 (0.00%)

At close: Feb 23, 2023, 10:00 PM

CinCor Pharma Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021	Q4 2020
Period Ending	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Income	-22.24M	-21.35M	-13.7M	-25.23M	-7.69M	-5.17M	-4.41M	-5.51M
Interest Income	1.27M	277.38K	51.45K	13.74K	1.95K	1.54K	4.41K	6.81K
Pretax Income	-20.98M	-21.08M	-16.7M	-29.34M	-9.02M	-6.38M	-5.62M	-5.81M
Net Income	-19.71M	-20.52M	-19.64M	-33.44M	-9.02M	-6.38M	-5.62M	-5.81M
Selling & General & Admin	4.52M	4.19M	4.03M	13.85M	3.04M	1.18M	923.57K	390.17K
Research & Development	17.73M	17.16M	9.67M	11.38M	4.65M	4M	3.49M	5.12M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	22.24M	21.35M	13.7M	25.23M	7.69M	5.17M	4.41M	5.51M
Interest Expense	1.27M	277.38K	51.45K	13.74K	1.95K	1.54K	4.41K	6.81K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	22.24M	21.35M	13.7M	25.23M	7.69M	5.17M	4.41M	5.51M
Income Tax Expense	-1.27M	-554.75K	2.94M	4.1M	n/a	n/a	n/a	n/a
Shares Outstanding (Basic)	40.81M	37.71M	33.43M	35.42M	35.42M	34.36M	34.36M	36.52M
Shares Outstanding (Diluted)	40.81M	37.71M	33.43M	35.42M	35.42M	34.36M	34.36M	36.52M
EPS (Basic)	-0.48	-0.54	-0.59	-0.94	-0.25	-0.19	-0.16	-0.16
EPS (Diluted)	-0.48	-0.54	-0.59	-0.94	-0.25	-0.19	-0.16	-0.16
EBITDA	-22.24M	-21.35M	-13.7M	-29.33M	-9.02M	-6.38M	-5.61M	-5.8M
EBIT	-19.71M	-20.8M	-16.65M	-29.33M	-9.02M	-6.38M	-5.61M	-5.8M
Depreciation & Amortization	4.21K	86.06K	3.04M	-4.1M	-1.33M	-1.21M	-1.2M	-288.81K